Some ACIP members argued woman older than 50 should also be singled out in warning for Johnson & Johnson’s COIVD-19 vaccine and said that people need to be more clearly told they can get alternative vaccines that don’t have this risk.
New updated US data on the rare blood clots seen in people who received Johnson & Johnson’s COVID-19 vaccine, including more reports in older people, caused some members of the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices to push for stronger warnings on the vaccine at a 12 May meeting.
The CDC’s Vaccine Safety Technical Work Group, which includes ACIP member Grace Lee, is continuing to recommend that the benefits...
If approved, Sanofi’s acoziborole could become the first single-dose oral treatment for sleeping sickness.
Mexico’s drugs regulator will be able to grant quicker drug approvals based on decisions issued by World Health Organization listed authorities and founding ICH members.
Biogen has U-turned on its original decision not to file Qalsody for marketing approval in the UK for treating certain patients with amyotrophic lateral sclerosis. The move appears to have been triggered by a change in the reimbursement pathway agreed for the product.
